2016-07-12 Assigned to IMMUNEXPRESS PTY LTD reassignment IMMUNEXPRESS PTY
LTD CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE ADDRESS FROM …

Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL
TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL …

2020-02-26 Assigned to AMPEL BIOSOLUTIONS, LLC reassignment AMPEL
BIOSOLUTIONS, LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …

The present invention discloses methods, kits, and apparatus as well as reagents and
compositions associated therewith for deriving an indicator for use in diagnosing the …

A method for validating quantification of biomarkers, the biomarkers being quantified using a
quantification technique of a selected type, and the method including determining a plurality …

US12006548B2 - Treating or inhibiting severe sepsis based on measuring defensin alpha 4
(DEFA4) expression - Google Patents US12006548B2 - Treating or inhibiting severe sepsis …

A system for disease prediction includes processing circuitry configured to receive a dataset
including data of a pa-tient population, the data including for each of a plurality of patients of …

The present disclosure provides methods for determining whether a subject has sepsis, or is
at risk of developing sepsis, and methods of treating the subject based on the determination …

US11673964B2 - Use of CD2/5/7 knock-out anti-CD2/5/7 chimeric antigen receptor T cells
against T cell lymphomas and leukemias - Google Patents US11673964B2 - Use of CD2/5/7 …

US11530258B2 - Use of SRSF3 agents for the treatment and/or prevention of neurological
conditions, cancer, bacterial infections or viral infections - Google Patents US11530258B2 …